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Abstract
Background
Obesity is one of the major public health challenges worldwide. It involves numerous endo-
crine disorders as etiological factors or as complications. Previous studies strongly sug-
gested the involvement of the hypothalamic-pituitary-adrenal (HPA) axis activity in obesity,
however, to date, no consistent trend in obesity-associated alterations of the HPA axis has
been identified. Aging has been demonstrated to aggravate obesity and to induce abnormal-
ities of the HPA axis. Thus, the question arises whether obesity is correlated with peripheral
indicators of HPA function in adult populations.
Objectives
We aimed to meta-analyze literature data on peripheral cortisol levels as indicators of HPA
activity in obesity during aging, in order to identify possible explanations for previous contra-
dictory findings and to suggest new approaches for future clinical studies.
Data Sources
3,596 records were identified through searching of PubMed, Embase and Cochrane Library
Database. Altogether 26 articles were suitable for analyses.
Study Eligibility Criteria
Empirical research papers were eligible provided that they reported data of healthy adult
individuals, included body mass index (BMI) and measured at least one relevant peripheral
cortisol parameter (i.e., either morning blood cortisol or 24-h urinary free cortisol).
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Statistical Methods
We used random effect models in each of the meta-analyses calculating with the DerSimo-
nian and Laird weighting methods. I-squared indicator and Q test were performed to assess
heterogeneity. Meta-regression was applied to explore the effect of BMI and age on morning
blood and urinary free cortisol levels. To assess publication bias Egger’s test was used.
Results
Obesity did not show any correlation with the studied peripheral cortisol values. On the other
hand, peripheral cortisol levels declined with aging within the obese, but not in the non-
obese groups.
Conclusions
Our analysis demonstrated that obesity or healthy aging does not lead to enhanced HPA
axis activity, peripheral cortisol levels rather decline with aging.
Introduction
Obesity, one of the major public health challenges of the world involves a great variety of endo-
crine disorders as etiological factors or as complications [1]. Previous studies suggested a
potential involvement of the hypothalamic-pituitary-adrenal (HPA) axis in obesity [2, 3].
Regarding the HPA axis, peripheral glucocorticoid hyperfunction is thought to be a major fac-
tor in correlation with obesity, either as an etiological factor of adiposity [3] or as a complica-
tion of weight gain [2]. On the other hand, central members of the axis would rather induce
weight loss [4–7]. In particular, hypothalamic corticotropin-releasing factor (CRF) the major
activator of the HPA axis is a well-known anorexigenic mediator [4, 5] and pro-opiomelano-
cortin, the precursor of adrenocorticotropin hormone (ACTH released from the anterior pitu-
itary upon CRF activation) also has anorexigenic derivatives, such as alpha-melanocyte
stimulating hormone [6, 7]. The potential involvement of glucocorticoids in obesity is sup-
ported by numerous factors (for review see [2, 3]). Among other actions, they induce gluco-
neogenesis leading to hyperglycemia and hyperinsulinemia promoting fat deposition in case
of enhanced caloric intake, they promote the differentiation and proliferation of human adipo-
cytes [8], and they also play a role in the development of metabolic syndrome associated with
visceral obesity [9]. Such findings raise the possibility that visceral fat accumulation and
enhanced activity of the HPA axis may be linked to each other, but characteristics of this rela-
tionship remain unknown [10].
Previous findings do not show consistent trends in obesity-related to HPA axis alterations.
While both positive and negative correlations have been found by different clinical observa-
tions, the most consistent feature reported by a number of studies was a negative linear rela-
tionship between body mass index (BMI) and morning serum or salivary cortisol levels [11–
16]. Interestingly, one study described even a non-linear, U-shaped relationship between BMI
and glucocorticoids: circadian slopes of salivary cortisol secretion were lowest in mildly over-
weight individuals (nadir), whereas high values were observed both in the severely obese and
in the low-normal BMI groups [14].
Aging is a major factor that influences HPA axis activity [17, 18] and at the same time, it is
also known to increase the prevalence of obesity reaching a peak in middle-aged populations
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[19]. No correlation of aging or BMI versus cortisol levels were described in healthy lean indi-
viduals [20, 21, 22]. In obesity, however a gradual increase in integrated daily cortisol release
has been described during the course of aging [23].
We aimed to review the literature on peripheral cortisol levels as indicators of HPA activity
in healthy adult individuals (above 18 years) with or without obesity during aging, comple-
mented by a meta-analysis of the available human data, in order to identify possible explana-
tions for previous contradictory findings and to suggest possible new approaches for future
clinical studies.
Methods
Search strategy and study selection
We performed this study following principles of the PRISMA statement [24]. No review proto-
col was registered for this meta-analysis. Database search was conducted in May 2016. Our
meta-analysis was based on the PICO format (P: adult individuals older than 18 years, I: mild/
severe obesity, C: normal body weight O: morning serum/plasma cortisol, 24- h urinary corti-
sol). Records (altogether 3596) were identified through searching of PubMed (http://www.
ncbi.nlm.nih.gov/pubmed), Embase (https://www.embase.com) and Cochrane Library Data-
base (http://www.cochranelibrary.com) (Fig 1). All together twenty-six articles were suitable
for analyses [25–50]. The following search strings were used alone and in combination: ‘obe-
sity’ and ‘obese’ and ‘overweight’ and ‘serum cortisol’ and ‘plasma cortisol’and ‘morning corti-
sol and ‘urinary cortisol’ and ‘UFC’. Search strategy of PubMed was as follows: (‘obesity’ OR
‘obese’ OR ‘overweight’) AND ‘(morning cortisol OR serum cortisol OR plasma cortisol)’;
(‘obesity’ OR ‘obese’ OR ‘overweight’) AND (‘urinary cortisol’ OR ‘UFC’). This search identi-
fied 1466 records.
Exclusion criteria included animal experiments, non-English language reports, steroid
treatment, endocrine diseases affecting the HPA axis (such as Cushing’s disease or syndrome,
androgen hyperactivity, polycystic ovary syndrome), pregnancy and psychiatric disorders
affecting the HPA axis (such as depression, anxiety, anorexia nervosa, etc.).
Clinical studies were eligible provided that they reported data of adult, predominantly
healthy individuals and included BMI and measured at least one relevant peripheral cortisol
parameter (i.e. either morning blood cortisol or 24-h urinary free cortisol).
Regarding assessment of risk of bias of individual studies, the fact that very few such reports
were available in the literature, precluded exclusion of them based on lack of randomized
design or low participant numbers. Such a risk of bias was relatively low, in any case. Our
study focused on correlations between physiological parameters, such as periheral cortisol lev-
els and BMI and/or age not on treatment efficacy, therefore blinding (to exclude placebo
effects) was of relatively minor relevance. Moreover, due to weighting methods, data with low
participant numbers were assigned with lower weights during the analysis.
Data extraction and evaluation procedure
Two authors (J.T., I.R.) independently performed study selection by following inclusion cri-
teria as indicated above. The following pieces of information were recorded for each study:
first author, publication year, sample size, gender, age, BMI, mean values of morning blood
cortisol in μg/dL and/or 24h- urinary free cortisol in μg/dL (Table 1). No supplementary
information was obtained from investigators of the original clinical studies, only published
data were used.
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Statistical methods
We used random effect models in each of the meta-analyses calculating with the DerSimonian
and Laird weighting method. Regarding summary measures (PRISMA [24]), primary analyses
demonstrate differences of means with 95% confidence intervals (95% CI) from studies that
contained data for obese and non-obese control groups, as well. Addititional analyses show
mean cortisol values of subgroups with 95% CI intervals (with summarized weighted means).
These groups of the clinical studies were assigned to non-obese (N, BMI < 25), mildly obese
(MO, 25 < BMI < 35) or severely obese (SO, BMI> 35) categories.
To assess whether the heterogeneity observed among effect sizes could be attributed to ran-
dom chance or other factors (different clinical methods or diverse participants), I-squared
indicator and Q test were performed. I-squared statistics represents the percentage of effect
size heterogeneity that cannot be explained by random chance but that is determined by other
Fig 1. Flowchart of the study selection procedure.
doi:10.1371/journal.pone.0166842.g001
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Table 1. Description of the studies included in the meta-analyses.
Study Sample
size
Gender Age Weight
group *
Morning blood
cortisol (μg/dL)
24-h urinary free
cortisol (μg/dL)
Relationship between BMI and
cortisol
Mean Mean ± SD Mean ± SD Morning blood
cortisol
24-h urinary free
cortisol
Arikan et al. (2009) [25] 30 female 24,64 N 12.28 ± 5.09 NR NR NR
Barat et al. (2005) [26] 44 female 33,00 SO 17.51 ± 5.11 NR NR NR
Bentley-Lewis et al. (2007)
[27]
57 both 43,00 MO 12.10 ± 3.77 58.50 ± 30.51 not significant not significant
63 37,00 N 12.50 ± 3.97 63.90 ± 50.58
Brumby et al. (2013) [28] 37 female 53,22 MO 13.55 ± 3.97 NR NR NR
Casulari et al. (2015) [29] 16 both 34,60 MO 7.19 ± 3.35 NR NR NR
Cizza et al. (2012) [30] 44 both 35,30 N 19.52 ± 8.50 62.19 ± 22.58 NR NR
Constantinopoulos et al.
(2015) [31]
18 both 34,70 SO 10.7 ± 4.10 71.30 ± 62.70 NR NR
Drent et al. (1995) [32] 24 both 46,70 MO 13.24 ± 4.32 NR NR NR
Duclos et al. (2014) [33] 22 female 33,63 SO 17.46 ± 5.05** 38.68 ± 16.29** NR not significant
31 35,40
Engeli et al. (2004) [34] 23 female 56,00 N 12.70 ± 6.10 19.00 ± 9.00 NR NR
23 57,00 MO 10.50 ± 40 24.00 ± 10.00
24 58,00 SO 8.90 ± 3.30 22.00 ± 11.00
Gambineri et al. (2014)
[35]
20 female 28,70 MO 12.43 ± 4.70 142 ± 58.14 NR NR
Hallschmid et al. (2006)
[36]
10 both NR
(range:
23–46)
MO 7.77 ± 2.53 NR NR NR
12 N 5.88 ± 2.08
Prpić-Krizˇevac et al.
(2012) [37]
29 both 49,40 MO 15.78 ± 4.92 57.79 ± 27.14 not significant not significant
19 46,10 N 17.96 ± 6.2 55.04 ± 21.34
Labouesse et al. (2014)
[38]
25 female 31,70 MO 11.60 ± 4.6 NR NR NR
Mota Martins et al. (2014)
[39]
40 female 28,15 N 9.89 ± 5.61 NR NR NR
40 32,33 SO 9.56 ± 4.86
Monteleone et al. (2003)
[40]
31 female 23,80 N 12.30 ± 4.80 NR NR NR
12 37,40 SO 120 ± 3.10
Mu¨ssig et al. (2008) [41] 72 both 39,30 SO 11.75 ± 5.94 39.90 ± 23.76 NR NR
30 30,30 N NR 40.10 ± 19.72
Olszanecka-Glinianowicz
et al. (2007) [42]
34 female 31,00 SO 13.66 ± 9.51 NR NR NR
Pasquali et al. (2002) [43] 13 male 35,60 N 13.33 ± 4.39** NR NR NR
21 female 31,60
21 male 39,70 SO 13.00 ± 5.09**
51 female 34,70
Putignano et al. (2001)
[44]
47 female 35,50 MO 13.90 ± 4.94 43.51 ± 27.08 negative linear
relationship
p<0.05
not significant
103 38,20 SO 12.20 ± 5.78 37.72 ± 21.01
63 31,20 N 15.20 ± 8.57 47.10 ± 29.37
Rask et al. (2001) [45] 11 male 46,80 N 10.33 ± 2.86 NR NR NR
11 49,60 MO 11.54 ± 3.87**
12 51,90
Schorr et al. (2015) [46] 21 female 30,00 MO 18.30 ± 6.80 67.00 ± 35.20 U-shaped
relationship
R = 0.45
p = 0.003
U-shaped
relationship
R = 0.47
p = 0.004
21 27,00 N 21.90 ± 8.90 51.10 ± 18.80
Shabir et al. (2013) [47] 55 female 25,00 N 11.30 ± 4.50 NR NR NR
(Continued )
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factors (mentioned above). If the Q test is significant, it implies that the heterogeneity among
effect sizes reported in the observed studies are more diverse than it could be explained only
by random error. We considered the Q test significant if p< 0.1.
We used meta-regression models to explore the effect of various factors on morning and
urinary free cortisol levels. In each case we tested the whole model (simultaneously hypothe-
sized that all coefficients are zero) and report the regression coefficients, 95% CI-s, standard
errors and z tests. We also calculated the explained variance of the model (R2 analog) and the
result of the Q test to evaluate if the unexplained variance is zero.
To compare the cortisol levels of non-obese, mildly and severely obese groups, we used sub-
group analysis, p< 0.05 indicating significant difference.
To assess the presence of publication bias, we used Egger’s test to detect asymmetry in the
funnel plot. A significant test result (p< 0.1) indicates the existence of bias.
Some studies reported the data (age, cortisol, etc.) separately for men and women or for dif-
ferent BMI groups. In these cases, it was possible to calculate the variance and the mean of the
whole group using the additivity of within-group sum of squares and between-group sum of
squares. From the sum of squares, variance was calculated. We report every instance where
such calculation was conducted (Table 1).
All statistical analyses were performed with Comprehensive Metaanalysis Software (Biostat
Inc.) and Stata 11 SE (Stata Corp.).
Results
Search results
In May 2016 3596 records were identified through database searching based on PICO (P: adult
individuals older than 18 years, I: mild/severe obesity, C: normal body weight O: morning
serum/plasma cortisol, 24- h urinary cortisol) from PubMed (n = 1466), from Embase
(n = 1967) and from Cochrane Library database (n = 167) and screened for duplicates (Fig 1).
From other sources (from reference lists of screened studies) 5 additional records were
obtained. Following further screening of non-English language articles, animal background,
lack of abstract or full-text availability and exclusion based on title and abstract evaluation, 228
records remained for detailed assessment of eligibility. Altogether 29 articles were chosen [25–
Table 1. (Continued)
Study Sample
size
Gender Age Weight
group *
Morning blood
cortisol (μg/dL)
24-h urinary free
cortisol (μg/dL)
Relationship between BMI and
cortisol
Mean Mean ± SD Mean ± SD Morning blood
cortisol
24-h urinary free
cortisol
Stewart et al. (1999) [48] 12 both 33,10 MO 16.35 ± 2.24** 47.75 ± 5.31 ** not significant not significant
12 33,90
12 27,90 N 16.93 ± 1.30 47.10 ± 7.50
Tomiyama et al. (2014)
[49]
47 female 40,89 MO 9.97 ± 1.48 NR NR NR
Vicennati et al. (2009) [50] 127 female 44,80 SO NR 38.20 ± 23.60 NR positive linear
relationship
p<0.001
21 34,00 N 21.10 ± 9.80
BMI, body mass index; NR, not reported
*Weight group indicates non-obese = N (BMI < 25), mildly obese = MO (25 < BMI < 35) or severely obese = SO (BMI > 35) participant groups
** indicate merged data
doi:10.1371/journal.pone.0166842.t001
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50], but finally only 26 proved to be eligible for statistical analysis, based on inadequate data
presentation (Fig 1).
Study characteristics
Studies used in our meta-analysis dated from 1995 to 2015. Data of 1511 individuals were
included in our analysis (number of participants ranged from 16 to 213 per study). From each
study sample size, gender, age, BMI, mean values of morning blood cortisol and/or 24h- uri-
nary free cortisol were extracted (Table 1).
Relatively few studies reported such values. Therefore we decided to include all data in our
meta-analysis without exclusion based on assessment of risk of bias of individual studies. This
risk of bias appeared to be low, since our study focused on correlations between physiological
parameters (periheral cortisol levels versus BMI and/or age) and not on treatment efficacy. In
our case, blinding of participants, to exclude placebo effects, was of minor importance. Due to
weighting methods, data with low participant numbers were assigned with lower weights in
our analysis.
Among the twenty-six studies only seven [27, 33, 37, 44, 46, 48, 50] investigated the rela-
tionship between BMI and HPA axis activity based on 24-h urinary free cortisol. In addition
five studies of the seven also measured morning blood cortisol [27, 37, 44, 46, 48]. In others no
correlation between these values was studied. Only one study found significant linear correla-
tion between obesity and morning blood cortisol of female participants [44], and one work
focusing also on female volunteers reported non-linear U-shaped relationship between morn-
ing blood cortisol or 24-h urinary free cortisol and BMI [46]. All other studies failed to reveal
any association between these values.
Regarding gender, the majority of the studies (fifteen of them) contained data regarding
morning blood cortisol and/or 24-h urinary free cortisol of women [25, 26, 28, 33–35, 37–39,
41, 44, 46, 47, 49, 50], four of which also tested the correlation between BMI and cortisol values
[33, 44, 46, 50]. Two of them found association between obesity and peripheral cortisol [44,
46]. One study reported morning blood cortisol data of male participants without analysing
potential correlation [45], and the remaining ten clinical studies pooled data of male and
female volunteers [27, 29–32, 36, 40, 42, 43, 48].
Regarding age, in most studies, mean age value (with SD) was given for a wide age-range of
the participants. This mean age exceeded 50 years only in three of the studies [28, 34, 45].
None examined association between cortisol values and age.
Primary analysis and publication bias
Regarding those eleven studies that contained values of morning blood cortisol of obese and
non-obese groups [27, 34, 36, 38, 39, 42–46, 48] the classic random effect model showed no
effect of obesity on this parameter in otherwise healthy adults (Fig 2). Weighted overall effect
size (ES) = -0.58 with 95% confidence interval (95% CI of -1.41, 0.25), p = 0.173. Heterogeneity
of the data was high: I-squared = 40.97%, p = 0.076, indicating the presence of other determin-
ing factors in the background.
Similar meta-analysis concerning 24-h urinary free cortisol (eight studies, [27, 34, 40, 43,
44, 46, 48, 50]) demonstrated a similar lack of overall effect (Fig 3). ES = 2.87 95% CI (-3.63,
9.37), p = 0.387. Heterogeneity of the data was high: I-squared = 81.3%, p< 0.0001, even more
strongly indicating the presence of other determining factors in the background.
No publication bias was identified using Egger’s test: p = 0.262 for morning blood cortisol
and p = 0.266 for 24-h urinary free cortisol.
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Additional analyses
Weighted mean peripheral cortisol values of N, MO or SO participant groups of all studies
(with or without calculation of correlation between BMI and peripheral cortisol) were also
analysed by subgroup analysis.
As shown in Fig 4, we found a lack of effect of mild or severe obesity on morning blood cor-
tisol. For category N: overall weighted mean was 13.56 with 95% CI (11.49, 15.63), relative
weight 36.17%. For category MO: overall weighted mean was 12.38 with 95% CI (10.85, 13.92),
relative weight 37.31%. For category SO: overall weighted mean was 12.66 with 95% CI (10.80,
14.52), relative weight 26.52%. High value of heterogeneity (I-squared: 95.50%, p< 0.0001) for
morning blood cortisol, indicates the contribution of other strong factors determining these
values.
Fig 5 demonstrates a lack of effect of mild or severe obesity on 24-h urinary cortisol. For cat-
egory N: overall weighted mean was 44.79 with 95% CI (33.26, 56.31), relative weight 43.76%.
For category MO: overall weighted mean was 48.26 with 95% CI (37.06, 59.46), relative weight
28.35%. For category SO: overall weighted mean was 36.82 with 95% CI (30.09, 43.54), relative
weight 27.90%. High value of heterogeneity (I-squared: 95.70%, p< 0.0001) for 24-h urinary
free cortisol indicates the contribution of other strong factors determining these values.
Fig 2. Forest plot representing the differences in mean morning blood cortisol values of obese and non-obese groups.
Squares show the difference in mean values with the grey area reflecting the weight assigned to the study. Horizontal bars indicate 95%
confidence intervals (95% CI). The diamond shows the overall effect size (ES) with its corresponding 95% CI.
doi:10.1371/journal.pone.0166842.g002
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Meta-regressions regarding correlation between BMI and morning blood cortisol or 24-h
urinary cortisol values also failed to show any singnificant effect (results not shown).
Concerning the effects of aging, meta-regression showed a slight but significant decline of
morning blood cortisol between 30 to 60 years of age (Fig 6). This negative correlation was
observed within the obese (number of groups: 26, coefficient: -0.14, p = 0.023, r-square ana-
logue: 0.34) and also in the merged groups (number of groups: 40, coefficient: -0.11, p = 0.027,
r-square analogue: 0.25), but not within the non-obese population (number of groups: 14,
coefficient: -0.02, p = 0.860). However, in both cases of significant linear correlations, the
goodness of fit test indicates that the unexplained variance is not zero (for the obese groups:
Q = 1110.19, df = 24, p< 0.0001, for the merged groups: Q = 1547.27, df = 38 p< 0.0001), sug-
gesting other determinig factors in the background.
A similar relationship (not shown) was observed between 24-h urinary free cortisol and
aging within the obese (number of groups: 15, coefficient: -0.78, p = 0.002, r-square analogue:
0.4) and the merged groups (number of groups: 24, coefficient: -0.93 p = 0.0007, r-square ana-
logue: 0.28), but not among normal, non-obese participants (number of groups: 9, coefficient:
-0.61, p = 0.315). However, in both cases of significant linear correlations, the goodness of fit
test indicates that the unexplained variance is not zero (for the obese groups: Q = 120.31,
df = 13, p< 0.0001, for the merged groups: Q = 312.5, df = 22, p< 0.0001), suggesting the role
of other determinig factors.
Fig 3. Forest plot representing the differences in mean 24-h urinary free cortisol values of obese and non-obese groups.
Squares show the difference in mean values with the grey area reflecting the weight assigned to the study. Horizontal bars indicate 95%
confidence intervals (95% CI). The diamond shows the overall effect size (ES) with its corresponding 95% CI.
doi:10.1371/journal.pone.0166842.g003
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Discussion
Our present study aimed to review the literature on markers of peripheral cortisol release
(morning blood cortisol and 24-h urinary free cortisol) as indicators of HPA axis activity in
obesity during aging in otherwise healthy, non-depressed adults, complemented by a meta-
Fig 4. Forest plot indicating the mean values of morning blood cortisol in non-obese (N), mildly (MO) or severely obese (SO)
groups. The grey areas reflect the weight assigned to the study. Horizontal bars indicate 95% confidence interval (95% CI). The
diamond indicates the weighted mean of each subgroup with the corresponding 95% CI. ES: effect size.
doi:10.1371/journal.pone.0166842.g004
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analysis of the available human data. We intended to identify possible explanations for previ-
ous contradictory findings and to suggest new methodological approaches for future clinical
studies.
Our results show that in predominantly healthy non-obese adults, BMI fails to influence
morning blood cortisol or 24-h urinary free cortisol values. Although experimental data con-
tinues to suggest that excess adiposity and obesity result in increased adrenal cortisol secretion
[2], meta-regression focusing on correlation between pooled BMI values (of non-obese, mildly
or severely obese populations) and peripheral (morning blood, or 24-h urinary) cortisol values,
failed to show significant effects. No such correlation was revealed in any of the obese sub-
groups either. These results are in contrast with findings of previous studies showing either
Fig 5. Forest plot indicating the mean values of 24-h urinary free cortisol in non-obese (N), mildly (MO) or severely obese (SO)
groups. The grey areas reflect the weight assigned to the study. Horizontal bars indicate 95% confidence interval (95% CI). The
diamond indicates the weighted mean of each subgroup with the corresponding 95% CI. ES: effect size.
doi:10.1371/journal.pone.0166842.g005
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decreased cortisol levels in obesity [11, 13–16, 51] or non-linear U-shaped correlation of
peripheral cortisol and BMI accross the BMI spectrum [46]. Moreover, high heterogeneity of
our data indicates that excessive variations in the data are not accidental, but suggests the pres-
ence of other determining factors in the background. Such determining factors could include
general life stress of the participants, unhealthy diet, light conditions or impaired sleep quality
(the latter two especially affects morning blood cortisol) [3, 52, 53], etc. Gender could also be
an important confounder [3, 54, 55]. In most available studies blood and urine samples were
collected from males and females and results were pooled. Gender differences could therefore
contribute to inconsistent trends in the results. In females, follicular or luteal phase of the men-
strual cycle, as well as pre- or post-menopausal status are also known to influence the HPA
axis activity [33, 56, 57]. Importance of such additional determining factors that may influence
peripheral cortisol release, independently of visceral obesity, are emphasized by previous clini-
cal findings [9, 31]. These previous studies report that higher cortisol levels appear to induce
metabolic syndrome in people suffering of severe visceral obesity, whereas similarly obese
individuals with low cortisol output do not show characteristics of metabolic syndrome [9,
31]. Thus, high cortisol output appears to aggravate complications of obesity.
Regarding aging, our analysis showed an age-related decline in peripheral cortisol values
from 30 to 60 years of age within the obese group. No such correlation was found in healthy
Fig 6. Meta-regression of mean morning blood cortisol levels versus mean age of the 26 obese groups from our analyzed
studies (Table 1).
doi:10.1371/journal.pone.0166842.g006
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individuals with normal BMI. Our results are in accord with previous observations based on a
relatively young cohort (mean age 33 ± 9.8) also showing age-related decline in cortisol values
[58]. These results, however, appear to contradict other reports that demonstrated increased
or maintained activity of the HPA axis during aging presumably participating in the develop-
ment of depression and frailty in the elderly [59–62]. Other investigators also suggested a role
for the hyperactive HPA axis in neuronal deterioration of aged humans and in old experimen-
tal animals [59, 63]. Our results are also contradictory with those works that reported a gradual
increase in integrated cortisol during the course of aging in obesity [23]. In conclusion, our
analysis suggests that aging per se does not necessarily lead to increased HPA axis activity in
healthy populations with or without obesity, but it will rather be associated with some decline
of peripheral cortisol output. Such a reduction in HPA axis activity during otherwise healthy
aging in obese populations, would slow down further progression of obesity and that of related
co-morbidities (such as type 2 diabetes mellitus or hypertension, etc.). On the other hand,
increases in HPA axis activity in obese or aging populations due to stress, sleep disorders,
unhealthy diet or other, as yet, undefined factors would promote the progression of obesity
and related co-morbidities [3, 52, 53]. Thus, our findings underline the importance of such
factors, the role of which may be more important in the development of obesity- or age-related
complications than that of obesity- or age-associated dysregulation of the HPA axis [46, 64].
It also has to be emphasized that our meta-analysis has numerous limitations mainly
because of the restricted availability of publications reporting suitable data. In our meta-analy-
sis, only BMI was available for the assessment of obesity, since very few studies reported appro-
priate data on fat content and fat distribution. Among them, visceral fat ratio could have been
the value most likely affected by variations in the HPA axis activity [53, 65]. Unfortunately, we
could not use such values in our analysis, due to insufficient data availability. Future studies
should be aimed to determine the correlation between visceral fat ratio and HPA axis activity
during the course of aging. In addition, among the twenty-six studies that we analyzed only
seven focused on the relationship between BMI and HPA axis activity based on 24-h urinary
free cortisol [27, 33, 37, 44, 46, 48, 50]. Five of these seven studies also reported morning blood
cortisol [27, 37, 44, 46, 48]. In the other nineteen studies no correlation between these values
was tested. Regarding the assessment of HPA axis activity, initially we have considered a num-
ber of potential variables also including cortisol awakening response curves (CAR, based on
salivary cortisol) [66], diurnal cortisol slope [67] and also hair cortisol (reflecting long-term
cortisol output) [68] as indicators. Once again, insufficient availability of data limited our
choice to morning blood cortisol (that is a technically simpler but less sensitive tool to evaluate
HPA axis activity than CAR) and 24-h urinary free cortisol (that reflects overall daily cortisol
output, albeit with high variations). Standardized evaluation of HPA axis activity in future
studies would greatly enhance the reliability and value of future meta-analyses. Regarding gen-
der, the majority of the studies (fifteen of them) contained data regarding morning blood cor-
tisol or 24-h urinary free cortisol of women [25, 26, 28, 33–35, 37–39, 41, 44, 46, 47, 49, 50],
four of which also tested the correlation between BMI and cortisol [33, 44, 46, 50]. Two of
them found some association between obesity and morning blood cortisol or urinary free cor-
tisol [44, 46]. One study reported morning blood cortisol data of male participants without
analyzing potential correlation [45], and the remaining ten clinical observations pooled data of
male and female volunteers [27, 29–32, 36, 40, 42, 43, 48]. These statistics suggest that an asso-
ciation between peripheral cortisol output and BMI would be more probably found in studies
focusing on women.
Concerning aging, hardly any paper was found that focused on old populations. Mean age
of the participants exceeded 50 years only in three of the studies [28, 34, 45]. None examined
association between cortisol values and BMI. In the available studies a high heterogeneity of
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age was found that could also contribute to some of the inconsistencies. In most studies, only
mean age value (with SD) was given for a wide age-range of the participants limiting the
strength of any correlation involving age.
Genetic, obesity- or age-related alterations in peripheral cortisol metabolism in muscles or
in adipose tissue may also contribute to confounders [34, 65, 69, 70]. Such alterations may
involve changes in the activity of 11-beta-hydroxysteroid dehydrogenase type I (activation) or
type II (deactivation). Some studies described an enhancement of 11-beta-hydroxysteroid
dehydrogenase type I (activation) activity in obesity [34] and also during the course of aging
[67, 71]. However, no conclusive evidence clarifies the role of these enzymes in obesity or
aging.
Concerning limitations of previous studies and potential explanation of the diverse find-
ings, we suggest that different sample techniques and assay methods may contribute to high
variations, especially in 24-h urinary free cortisol values. Moreover, 24-h urinary free cortisol
measurements were not corrected for creatinine excretion or body surface area. Body compo-
sition (fat mass) data were not included either in the available studies, which could also con-
tribute to the limited strength of the results. Small number of participants also limited the
weight of the results in most studies.
In conclusion, findings of our meta-analysis suggest that neither obesity, nor healthy aging
is necessarily associated with increased HPA axis activity (as indicated by peripheral cortisol
output) in otherwise healthy populations. Peripheral cortisol levels rather decline with aging.
However, since increased peripheral cortisol output aggravates consequences of both obesity
and aging, investigation of other determinig factors of HPA axis activity is of outstanding
importance.
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